About Us

Spondyloarthritis (SpA) is a term encompassing a wide spectrum of diseases including axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), enteropathic arthritis (eSpA), reactive SpA (reSpA), juvenile SpA (jSpA) and undifferentiated SpA (uSpA).

The last few decades have seen major advances in our understanding of SpA epidemiology, aetiology, pathology and presentation. A number of highly specialised laboratory and imaging techniques have been developed to better assess patients with SpA, both in terms of diagnosis, disease monitoring and predicting outcome. Perhaps most importantly of all, several biological agents and small-molecule therapies have been licenced to manage these historically difficult to treat conditions. Allied with these novel pharmacological therapies, there have been advances in physical and occupational therapies, to manage this complex multi-faceted group of diseases.

Patients are increasingly demanding uniform access to the expert care they deserve. Following the success of The East of England SpA Academy formed in 2017, The London (2019) and Scotland (2020) SpA Academies were established to raise clinical standards, promote multidisciplinary care, and generate research interest in spondyloarthritis. We hope to provide an overarching strategy to SpA learning, with central co-ordination to cover the wide breadth of topics relevant to practitioners managing SpA, and to avoid repetition of topics and presentations.

During 2021 we are establishing a UK wide Physiotherapy Academy and  Midland region SpA Academy in addition to annual updates in the Esat of England, London and Scotland. Each day has a theme and will cover all topics pertinent to the care of patients with SpA :  Presentation and care pathways;  clinical assessment;  Imaging and Case Studies; Pharmacological and non-pharmacological management. Due to Covid, these meetings will be virtual however we are hoping to re-establish face to events towards the end of the fear if this is considered safe.  Continuous  Professional Development (CPD) credits will be applied for retrospectively.

Please see the Events section of the website for further information.

Target audience:

  • Rheumatologists (consultants, associate specialists, staff grades, specialist registrars, fellows)
  • Other doctors (General Practitioners, Elderly Care physicians, Orthopaedic surgeons, others welcome too)
  • Nurses (specialist clinical nurse and research nurses)
  • Physiotherapists
  • Occupational therapists and orthotists
  • Pharmacists
  • Others (osteopaths, psychologists, dieticians, podiatrists)

Please register for upcoming events by using the ‘Events’ tab above.

Our Team

Professor Karl Gaffney
Read more….
Read more….